Search company, investor...

Catabasis Pharmaceuticals



Total Raised


Market Cap


Stock Price


About Catabasis Pharmaceuticals

Catabasis is a clinical stage biotechnology company with a robust portfolio of investigational new medicines for the treatment of cardiovascular, metabolic and inflammatory diseases. The company's drug development programs are rooted in the principles of Pathway Pharmacology, the treatment of diseases by simultaneously modulating more than one target in a disease pathway. Using its SMART (Safely Metabolized And Rationally Targeted) linker technology, we conjugate two drugs that act on different components of a disease pathway to produce new chemical entities with improved safety, tolerability and significantly enhanced efficacy. This approach has allowed Catabasis to move rapidly from concept to investigational new drug (IND) application, and to produce new medicines with superior efficacy.

Headquarters Location

One Kendall Square Bldg 1400E Suite B14202

Cambridge, Massachusetts, 02139,

United States


Missing: Catabasis Pharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Catabasis Pharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Catabasis Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Catabasis Pharmaceuticals is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Catabasis Pharmaceuticals Patents

Catabasis Pharmaceuticals has filed 52 patents.

The 3 most popular patent topics include:

  • Rare diseases
  • Glucocorticoids
  • Muscular dystrophy
patents chart

Application Date

Grant Date


Related Topics




Rare diseases, Fatty acids, Olfactory receptors, Cell biology, Cystic fibrosis


Application Date


Grant Date



Related Topics

Rare diseases, Fatty acids, Olfactory receptors, Cell biology, Cystic fibrosis



Latest Catabasis Pharmaceuticals News

Global Duchenne Muscular Dystrophy Market - Industry Trends and Forecast to 2027

Jun 17, 2022

Competitive Landscape and Global Duchenne Muscular Dystrophy Market Share Analysis·       Pfizer Inc, Sarepta Therapeutics ·       PTC Therapeutics, FibroGen Inc·       F. Hoffmann-La Roche Ltd,·       ITALFARMACO S. A·       BioMarin, Catabasis Pharmaceuticals, Inc·       ReveraGen BioPharma, Inc·       Bristol-Myers Squibb Company ·       Novartis AG, Hikma Pharmaceuticals PLC·       Endo International IncGet Full Access Of Report https://www. com/reports/global-duchenne-muscular-dystrophy-market MAJOR TOC OF THE REPORTØ INTRODUCTIONØ MARKET SEGMENTATIONØ EXECUTIVE SUMMARYØ PREMIUM INSIGHTSØ MARKET OVERVIEWØ MARKET, COMPANY LANDSCAPEØ SWOT ANALYSISØ COMPANY PROFILEØ QUESTIONNAIRERELATED REPORTSGet TOC Details https://www. comBrowse Related Reports@ Global Hollow Core Insulator Market                                       Global Duchenne Muscular Dystrophy Market

Catabasis Pharmaceuticals Frequently Asked Questions (FAQ)

  • Where is Catabasis Pharmaceuticals's headquarters?

    Catabasis Pharmaceuticals's headquarters is located at One Kendall Square, Cambridge.

  • What is Catabasis Pharmaceuticals's latest funding round?

    Catabasis Pharmaceuticals's latest funding round is PIPE.

  • How much did Catabasis Pharmaceuticals raise?

    Catabasis Pharmaceuticals raised a total of $103.49M.

  • Who are the investors of Catabasis Pharmaceuticals?

    Investors of Catabasis Pharmaceuticals include Perceptive Advisors, MedImmune Ventures, SV Health Investors, Clarus, Advanced Technology Ventures and 4 more.

  • Who are Catabasis Pharmaceuticals's competitors?

    Competitors of Catabasis Pharmaceuticals include Aquinox Pharmaceuticals, Relypsa, Anacor Pharmaceuticals, Tolera Therapeutics, BioRelix and 14 more.

Compare Catabasis Pharmaceuticals to Competitors

Avidimer Therpeutics

Avidimer Therapeutics is engaged in the discovery and development of therapeutics for inflammatory diseases


is engaged in endocannabinoid research with the ability to address major unmet medical needs for selected diseases with clear competitive advantage over present therapies. The company's mission is the discovery, development and commercialization of therapeutics in the areas of neuropathic, inflammatory and somatic pain, obesity, neuroprotection, and addiction and glaucoma.

Aderis Pharmaceuticals

Aderis Pharmaceuticals, formerly Discovery Therapeutics, develops and commercializes small molecule, receptor-specific therapeutics for the treatment of central nervous system, cardiovascular and renal diseases.


SBIO is focused on the discovery and development of small molecule oncology drugs.

CoImmune Logo

CoImmune, fka Argos Therapeutics, is a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases. Using biological components from each patient, the company's immunotherapies employ the patient's dendritic cells to activate an immune response specific to the patient's disease.

Verva Pharmaceuticals

Verva Pharmaceuticals is an exciting, clinical-stage pharmaceutical company focused on the discovery and development of therapies to treat metabolic diseases (formerly Adipogen).

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.